Market Overview

Not Too Late to Buy Baxter, Jim Cramer Says

Share:
Related BAX
Goldman Remains Constructive on MedTech, Sees 'New Opportunities' Amid Selloff
Dan Loeb Is Still Bullish On Amgen, Allergan and Dow Chemical

Coming out of the Twittersphere late Thursday night: Jim Cramer offers advice to an investor who missed out on scooping up shares of Baxter International (NYSE: BAX) before the company announced a breakup into two separate, independent global healthcare companies.

Cramer, who correctly predicted Baxter's breakup, believes the stock can still be bought.

Shares of Baxter opened at $75.68, but closed at $72.80, finishing up 3.8 percent on Thursday.

Posted-In: Jim CramerAnalyst Color Jim Cramer Media Trading Ideas

 

Related Articles (BAX)

Get Benzinga's Newsletters